% | $
Quotes you view appear here for quick access.

Synageva BioPharma Corp. (GEVA) Message Board

fatty_mcknuckles 1 post  |  Last Activity: Jul 27, 2015 12:30 PM Member since: Jan 8, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by jpust47573 Jul 27, 2015 9:50 AM
    fatty_mcknuckles fatty_mcknuckles Jul 27, 2015 12:30 PM Flag

    This is odd. Stock has shot up, so it's understandable if an analyst says they think it's now overvalued. But MS underwrote the recent secondary at $120. Given RARE is buyout candidate, this looks a bit suspicious.

    Also, seems a bit of an overreaction to an analyst's opinion.

238.600.00(0.00%)Jun 22 3:59 PMEDT